Summary of study design among underlying trials. (A) Study flow... | Download Scientific Diagram
Pharmaceutics | Free Full-Text | Model-Informed Precision Dosing during Infliximab Induction Therapy Reduces Variability in Exposure and Endoscopic Improvement between Patients with Ulcerative Colitis
Clinical Information | REMICADE® (infliximab) HCP
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Infliximab bei aktiver Colitis ulcerosa – Wirksamkeit als Induktions- und Erhaltungstherapie nachgewiesen
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial - The Lancet Gastroenterology & Hepatology
High infliximab trough concentrations are associated with sustained histologic remission in inflammatory bowel disease: a prospective cohort study | BMC Gastroenterology | Full Text
Summary of Primary and Secondary Efficacy Results from ACT 1 and ACT 2.* | Download Table
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Dosing & Administration | REMICADE® (infliximab) HCP
Summary of Primary and Secondary Efficacy Results from ACT 1 and ACT 2.* | Download Table
Clinical Information | REMICADE® (infliximab) HCP
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan | BMC Pediatrics | Full Text
AUSTRALIAN PRODUCT INFORMATION – INFLECTRA® (infliximab (rmc))
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis | NEJM
Comparative efficacy of antitumor necrosis factor agents and tacrolimus in naïve steroid-refractory ulcerative colitis patients | Scientific Reports
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
Colectomy Rate Comparison After Treatment of Ulcerative Colitis With Placebo or Infliximab - ScienceDirect
Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response - Gary R. Lichtenstein, 2013
Optimizing management in IBD: Mucosal healing
Infliximab - Wikipedia
Summary of Primary and Secondary Efficacy Results from ACT 1 and ACT 2.* | Download Table
